Vericel price target raised to 67 from 61 at Truist

VCEL Stock  USD 59.08  0.00  0.00%   
About 55% of Vericel Corp's institutional investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Vericel Corp Ord suggests that some traders are interested. Vericel Corp's investing sentiment shows overall attitude of investors towards Vericel Corp Ord.
  
Truist analyst Richard Newitter raised the firms price target on Vericel to 67 from 61 and keeps a Buy rating on the shares as part of a broader research note previewing 2025 in Medical Technology. The firm sees the sector as one of the bettersafer houses in healthcare given its lower front-line exposure to healthcare policy rhetoric that is tied to the administration change as well as its position as an innovation segment with sustainable above-average revenue and EPS growth, s

Read at finance.yahoo.com
Yahoo News
  

Vericel Corp Ord Current Investor Sentiment

Panic Vs Confidence

55

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Vericel Corp's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Vericel Corp Ord.

Vericel Corp Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Vericel Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Vericel Corp Ord Historical Investor Sentiment

Investor biases related to Vericel Corp's public news can be used to forecast risks associated with an investment in Vericel. The trend in average sentiment can be used to explain how an investor holding Vericel can time the market purely based on public headlines and social activities around Vericel Corp Ord. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Vericel Corp's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Vericel Corp and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Vericel Corp news discussions. The higher the estimate score, the more favorable the investor's outlook on Vericel Corp.

Vericel Corp Maximum Pain Price Across April 17th 2025 Option Contracts

Vericel Corp's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Vericel Corp close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Vericel Corp's options.

Vericel Corp Fundamental Analysis

We analyze Vericel Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vericel Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vericel Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash And Equivalents

Cash And Equivalents Comparative Analysis

Vericel Corp is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Vericel Corp Ord Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vericel Corp stock to make a market-neutral strategy. Peer analysis of Vericel Corp could also be used in its relative valuation, which is a method of valuing Vericel Corp by comparing valuation metrics with similar companies.

Peers

Vericel Corp Related Equities

MREOMereo BioPharma   4.20   
0%
100.0%
RLAYRelay Therapeutics   3.24   
0%
77.0%
KROSKeros Therapeutics   3.23   
0%
76.0%
RGNXRegenxbio   3.08   
0%
73.0%
XFORX4 Pharmaceuticals   2.45   
0%
58.0%
CRNXCrinetics Pharmaceuticals   2.38   
0%
56.0%
STOKStoke Therapeutics   2.35   
0%
55.0%
RVMDRevolution Medicines   0.98   
0%
23.0%
SNDXSyndax Pharmaceuticals   0.62   
0%
14.0%
BPMCBlueprint Medicines   0.59   
0%
14.0%
CLGNCollplant Biotechnologies   0.50   
0%
11.0%
DYNDyne Therapeutics   0.00   
0%
0%
TERNTerns Pharmaceuticals   0.00   
0%
0%
MRUSMerus BV   0.50   
11.0%
0%
IPSCCentury Therapeutics   0.55   
13.0%
0%
DAWNDay One   0.88   
20.0%
0%
IDYAIdeaya Biosciences   2.38   
56.0%
0%
CYTKCytokinetics   2.66   
63.0%
0%
CMRXChimerix   3.01   
71.0%
0%
PLRXPliant Therapeutics   3.36   
80.0%
0%
XNCRXencor   3.94   
93.0%
0%
When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.045
Earnings Share
0.08
Revenue Per Share
4.685
Quarterly Revenue Growth
0.27
Return On Assets
(0)
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.